is semaglutide new Key lawmaker wants CT to explore partnership to manufacture weight-loss drugs Powerful new obesity drug poised

In most cases, a missed dose can be administered within a specific time window or skipped until the next scheduled injection

A generic version of injectable semaglutide is now available in Canada after regulators approved a copycat version of the GLP-1 weight loss best seller on Tuesday

In Study 1 (NCT00554216), patients with obesity (BMI greater than or equal to 35 kg/m2) were randomized to receive 1 year of treatment with placebo (N=514), phentermine and topiramate extended-release 3.75 mg/23 mg (N=241), or phentermine and topiramate extended-release 15 mg/92 mg (N=512) in a 2:1:2 ratio

Over several weeks, patterns emerge that guide optimization